METASTATIC MALIGNANT NEOPLASM
Clinical trials for METASTATIC MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug targets BRCA mutations beyond breast and ovarian
Disease control OngoingThis phase 2 trial tests the drug talazoparib in 150 people with advanced cancers that have not responded to standard treatments. Participants must have specific gene changes in BRCA1, BRCA2, or related DNA repair genes. The drug works by blocking an enzyme that helps cancer cell…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Gene-Targeted cancer therapy put to the test in major trial
Disease control OngoingThis study tests whether choosing cancer treatment based on the genetic makeup of a patient's tumor works better than standard therapy. Over 1,300 people with metastatic cancer are randomly assigned to receive either a targeted drug matched to their tumor's mutations or standard …
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Freezing cancer cells: could cryoablation boost immunotherapy?
Disease control OngoingThis study tests whether adding cryoablation—a procedure that freezes and kills cancer cells—can improve the effectiveness of standard immunotherapy in people with metastatic cancer. Fifteen participants will receive both treatments, and researchers will measure how many patients…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New study aims to ease agitated delirium in dying cancer patients
Symptom relief OngoingThis study looks at how well two drugs, haloperidol and lorazepam, can control severe agitation and confusion (delirium) in people with advanced cancer who are in palliative care. About 110 patients will be enrolled to compare different drug approaches. The goal is to improve com…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Fatigue-Busting combo: stimulant plus exercise tested in cancer patients
Symptom relief OngoingThis phase III trial tests whether the stimulant methylphenidate (Ritalin) combined with physical activity can reduce cancer-related fatigue in 212 patients with metastatic cancer who are receiving anti-PD1 immunotherapy. Participants are randomly assigned to receive either methy…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Exercise plus steroid pill may fight cancer fatigue
Symptom relief OngoingThis study tests whether adding a short course of the steroid dexamethasone to a physical activity program can better reduce severe fatigue in people with advanced cancer. About 90 participants will be randomly assigned to receive either a high or low dose of dexamethasone along …
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Can a common antipsychotic combo calm delirium in dying cancer patients?
Symptom relief OngoingThis study tests whether giving haloperidol alone or with chlorpromazine can safely calm severe agitation and confusion (delirium) in 70 advanced cancer patients in a palliative care unit. The main goal is to see if the drugs improve sedation scores within 24 hours. It is a phase…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New radiation approach may spare thinking skills in brain cancer patients
Symptom relief OngoingThis study compares two radiation treatments for people whose non-melanoma cancer has spread to the brain with 4 to 15 tumors. One method, stereotactic radiosurgery, delivers a high dose only to the tumors, while the other treats the whole brain. The goal is to see which better c…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Cancer patients vote: exam room or waiting room?
Knowledge-focused OngoingThis study asks cancer patients and their caregivers whether they would rather wait in an exam room or a waiting room when they arrive at the clinic. The goal is to understand their preferences to improve the clinic experience. About 406 people with advanced cancer and their care…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Money worries weigh heavy on advanced cancer patients
Knowledge-focused OngoingThis study looks at how serious money problems are for people with advanced cancer. Researchers will survey 141 patients to measure financial distress and see if it is linked to their symptoms and quality of life. The goal is to understand the burden of cancer costs, not to test …
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC